ZEVRA THERAPEUTICS, INC. (ZVRA) has 32 open-market insider trades by 15 insiders since 2023. Over the last six months insiders net sold $138K. The most active filer is Corey Michael Watton, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Neil F. McFarlane | CEOPres | — | 1 | $853K | 2026-10-12 |
| John B. Bode | Dir | — | 5 | $286K | 2026-03-24 |
| Alvin Shih | Dir | — | 1 | $158K | 2025-09-12 |
| Corey Michael Watton | Dir | — | 6 | $150K | 2026-08-10 |
| Thomas Anderson | Dir | — | 2 | $117K | 2024-07-16 |
| Joshua Schafer | CCO | — | 4 | $47K | 2026-02-03 |
| Matthew R. Plooster | Dir | — | 1 | $46K | 2023-03-09 |
| Richard W. Pascoe | CEO | — | 1 | $42K | 2023-03-09 |
| Adrian W. Quartel | — | — | 1 | $40K | 2026-01-30 |
| R. LaDuane Clifton | CFOTreasurer | — | 4 | $39K | 2025-12-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Neil F. McFarlane | CEO & President | Sell | $225K | 2026-10-12 |
| Rahsaan Thompson | CLO | Sell | $475K | 2026-08-14 |
| Corey Michael Watton | Director | Sell | $138K | 2026-08-10 |
| Rahsaan Thompson | CLO | Sell | $438K | 2026-06-22 |
| Rahsaan Thompson | CLO | Sell | $20K | 2026-05-11 |
| Neil F. McFarlane | President | Sell | $125K | 2026-02-09 |
Companies that share insiders with ZVRA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Joshua Schafer | CCO | Sell | $96K | 2026-02-03 |
| Timothy J. Sangiovanni | Controller & SVP | Sell | $28K | 2026-02-03 |
| Neil F. McFarlane | CEO & President | Sell | $853K | 2026-02-02 |
| Rahsaan Thompson | CLO | Sell | $36K | 2026-01-30 |
| Timothy J. Sangiovanni | VP & Controller | Sell | $15K | 2026-01-30 |
| Adrian W. Quartel | — | Sell | $40K | 2026-01-30 |
| Joshua Schafer | CCO | Sell | $30K | 2026-01-30 |
| Neil F. McFarlane | CEO & President | Sell | $211K | 2025-10-10 |
| Tamara A. Favorito | Director | Buy | $25K | 2025-09-12 |